About Us

Aegle Therapeutics is a regenerative medicine company developing novel therapeutics based on our proprietary extracellular vesicle isolation technology. We are isolating extracellular vesicles secreted by bone marrow derived mesenchymal stem cells (“MSCs”) to harness the regenerative healing power of stem cells without using the cells as therapy. Our extracellular vesicle therapy is being developed to treat burns, scarring, epidermolysis bullosa and chronic wounds as well as other indications such as stroke.

Aegle’s proprietary isolation process is easy to scale, low cost and produces EVs with an extended shelf life.